[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_99":100},"en-item",{"_9":10,"_10":11},"kind","item",{"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":31,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":-5,"_48":49,"_50":-5,"_51":-5,"_52":53,"_54":55,"_56":57,"_58":42,"_59":42,"_60":61,"_62":42,"_63":64},"id","onyo7j6p867fb1z3s5udi3c9c","revision",2,"title","Rogers Corporation公布截至2026年9月30日的第三季度及前九个月业绩：净销售额分别为2.361亿美元和6.534亿美元","originalTitle","10-Q - ROGERS CORP (0000084748) (Filer)","summary","Rogers Corporation披露，截至2026年9月30日的第三季度净销售额为2.361亿美元，净收入为2,260万美元，摊薄每股收益为1.26美元；前九个月净销售额为6.534亿美元，净收入为4,070万美元，摊薄每股收益为2.27美元。","reason","这份未经审计的中期报告呈现销售额与净收入变化、现金流和回购情况，并披露石棉索赔及保险回收估计存在不确定性。","source",{"_12":90,"_91":92,"_9":93,"_94":42,"_95":96,"_97":98},"links",{"_87":88,"_78":89},"publishedAt","2026-10-27T21:40:48.000Z","discoveredAt","2026-10-28T16:59:10.620Z","timelineAt","category","ai-products","tags",[84,85,86],"stockSymbols",[83],"score",62,"selected",true,"channel","news","story",{"_73":74,"_16":75},"x","readingMode","full","author","language","body",{"_64":77,"_78":-5,"_79":80,"_81":82},"outline",[],"relatedStories",[76],"indexable","markdownAvailable","group",{"_65":66,"_45":67,"_68":69,"_70":71,"_72":71},"hasTranslation","bodyLanguage","zh","factId","f4PjpFM07izg",{"_73":74,"_16":75},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","b519c03d-1a3c-4af0-987a-038a575b9d85","Rogers第三季度业绩及第四季度展望",{"_73":74,"_16":75},"

美国

证券交易委员会

华盛顿特区 20549

_______________________________

10-Q 表

_______________________________


☒	根据《1934 年证券交易法》第 13 或 15(d) 条提交的季度报告

截至 2026 年 9 月 30 日的季度期间

或


☐	根据《1934 年证券交易法》第 13 或 15(d) 条提交的过渡报告

过渡期间：自 _______________ 至 _______________

委员会档案编号 1-4347

_______________________________

ROGERS CORPORATION

（注册人章程中规定的确切名称）

_______________________________


马萨诸塞州	06-0513860
（州或其他司法管辖区）	（美国国税局雇主识别号）
注册成立或组织）

2225 W. Chandler Blvd., Chandler, Arizona 85224-6155

（主要执行办公室地址）（邮政编码）

注册人电话号码（含区号）：(480) 917-6000

根据该法第 12(b) 条注册的证券：


各类别名称	交易代码	上市交易所名称
股本，	每股面值 $1.00	ROG	纽约证券交易所

请勾选说明注册人是否：(1) 已在此前 12 个月内（或注册人须提交此类报告的较短期间内）提交《1934 年证券交易法》第 13 或 15(d) 条规定须提交的所有报告；且 (2) 在过去 90 天内一直受此类申报要求约束。是 ☒ 否 ☐

请勾选说明注册人是否已在此前 12 个月内（或注册人须提交此类文件的较短期间内）以电子方式提交根据 S-T 条例第 405 条（本章 § 232.405）须提交的所有交互式数据文件。是 ☒ 否 ☐

请勾选说明注册人是大型加速申报公司、加速申报公司、非加速申报公司、较小申报公司，还是新兴成长型公司。请参阅《交易法》规则 12b-2 中“大型加速申报公司”“加速申报公司”“较小申报公司”和“新兴成长型公司”的定义。


大型加速申报公司	☒	加速申报公司	☐
非加速申报公司	☐	较小申报公司	☐
		新兴成长型公司	☐

如果是新兴成长型公司，请勾选说明注册人是否选择不采用《交易法》第 13(a) 条规定的、遵守任何新颁布或修订的财务会计准则的延长过渡期。 ☐

请勾选说明注册人是否为空壳公司（定义见该法规则 12b-2）。是 ☐ 否 ☒

截至 2026 年 10 月 23 日，注册人已发行在外的股本为 17,795,440 股.

ROGERS CORPORATION

10-Q 表

2026 年 9 月 30 日


目录
第一部分 – 财务信息
	第 1 项。	简明合并财务报表（未经审计）：
		简明合并经营报表	4
		简明合并综合收益（亏损）报表	5
		简明合并财务状况表	6
		简明合并股东权益报表	7
		简明合并现金流量表	8
		简明合并财务报表附注	9
	第2项。	管理层对经营业绩和财务状况的讨论与分析	26
	第3项。	市场风险的定量和定性披露	32
	第4项。	控制与程序	32

第二部分 – 其他信息
	第1项。	法律诉讼	33
	第1A项。	风险因素	33
	第2项.	未注册股权证券的销售及所得款项用途	33
	第5项。	其他信息	33
	第6项。	附件	34
		签名	35

前瞻性陈述

本10-Q表季度报告（本“10-Q表”）包含《1933年证券法》（经修订）（“证券法”）第27A条及《1934年证券交易法》（经修订）第21E条所指的“前瞻性陈述”。有关更多信息，请参阅第2项“管理层对经营业绩和财务状况的讨论与分析”中的“前瞻性陈述”。

ROGERS CORPORATION

定义术语(1)


术语	定义
ADAS	高级驾驶辅助系统
AES	先进电子解决方案
APAC	亚太地区
ASC	会计准则编纂
ASU	会计准则更新
CODM	首席经营决策者
EMEA	欧洲、中东和非洲
EMS	弹性体材料解决方案
ERP	企业资源规划

EV/HEV	电动汽车/混合动力电动汽车
《交易法》	经修订的《1934年证券交易法》
FASB	财务会计准则委员会
第五次修订信贷协议	Rogers Corporation、届时作为协议当事方的贷款人、作为行政代理的JPMorgan Chase Bank, N.A.以及作为共同牵头安排代理的HSBC Bank USA, National Association、Wells Fargo Bank, National Association、Citibank, N.A.和Citizens Bank, N.A.于2023年3月24日签订的第五次修订及重述信贷协议
担保人	现有及未来的重要境内子公司

OECD	经济合作与发展组织
R&D	研究与开发


SEC	美国证券交易委员会
SG&A	销售、一般及行政


工会计划	Rogers Corporation 员工养老金计划
美国	美利坚合众国
美国公认会计原则	美国普遍接受的会计原则

(1)本 10-Q 表格中使用的某些术语在上表中定义。

第一部分——财务信息

项目 1. 财务报表

ROGERS CORPORATION

简明合并经营报表

（未经审计）

（金额和股数以百万计，每股金额除外）


	截至三个月		截至九个月
	2026年9月30日		2025年9月30日		2026年9月30日		2025年9月30日
净销售额	$	236.1			$	216.0		$	653.4	$	609.3
销售成本	155.4			143.7			437.7		416.0
毛利	80.7			72.3			215.7		193.3

销售、一般及行政费用	42.6			41.6			126.0		134.6
研发费用	7.0			7.4			21.0		21.5
重组、资产减值及其他费用	1.0			7.1			7.6		89.1
其他营业费用，净额	—			0.5			0.3		0.2
营业收入（亏损）	30.1			15.7			60.8		(52.1)

其他收入（费用），净额	0.3			0.4			1.7		(3.4)
利息收入，净额	0.6			0.2			1.2		0.9
所得税前收入（亏损）	31.0			16.3			63.7		(54.6)
所得税费用	8.4			7.7			23.0		11.8
净收入（亏损）	$	22.6			$	8.6		$	40.7	$	(66.4)

基本每股收益（亏损）	$	1.27			$	0.48		$	2.29	$	(3.63)
摊薄每股收益（亏损）	$	1.26			$	0.48		$	2.27	$	(3.63)

计算所用股数：
基本每股收益（亏损）	17.8			18.1			17.8		18.3
摊薄每股收益（亏损）	17.9			18.1			17.9		18.3

随附附注是简明合并财务报表不可分割的组成部分。

ROGERS CORPORATION

简明合并综合收益（亏损）表

（未经审计）

（金额以百万计）


	截至三个月		截至九个月
	2026年9月30日		2025年9月30日		2026年9月30日		2025年9月30日
净收入（亏损）	$	22.6			$	8.6		$	40.7	$	(66.4)

外币折算调整	2.4			(3.3)			(7.5)		47.9
养老金及其他退休后福利：

损失摊销，扣除税项后（附注 2）	0.1			—			0.2		0.2
其他综合收益（亏损）	2.5			(3.3)			(7.3)		48.1
综合收益（亏损）	$	25.1			$	5.3		$	33.4	$	(18.3)

随附附注是简明合并财务报表不可分割的组成部分。

ROGERS CORPORATION

简明合并财务状况表

（未经审计）

（金额和股数以百万计，面值除外）


	2026年9月30日		2025年12月31日
资产
流动资产
现金及现金等价物	$	206.1			$	197.0
短期投资	30.3			—
应收账款，净额	155.4			130.6
合同资产	29.0			27.9
存货，净额	130.6			125.0
石棉相关保险应收款，流动部分	4.7			4.7
其他流动资产	16.7			14.8
流动资产总额	572.8			500.0
不动产、厂房及设备，净额	353.5			372.4
经营租赁使用权资产	13.7			19.2
商誉	303.0			303.4
无形资产，扣除累计摊销后	90.7			99.3
石棉相关保险应收款，非流动部分	48.1			48.1
递延所得税	58.4			67.0
其他长期资产	19.6			20.5
资产总额	$	1,459.8			$	1,429.9
负债和股东权益
流动负债
应付账款	$	63.3			$	42.9
应计员工福利和薪酬	38.2			43.2
应计应付所得税	6.6			10.2
经营租赁义务，流动部分	3.4			3.9
石棉相关负债，流动部分	5.5			5.5
其他应计负债	21.5			20.4
流动负债合计	138.5			126.1

经营租赁义务，非流动部分	10.8			17.9
石棉相关负债，非流动部分	51.4			51.9
非流动所得税	5.1			4.8
递延所得税	17.6			17.7
其他长期负债	14.3			15.8
承诺和或有事项（附注9）
股东权益
股本——面值 $1；授权股数 50.0；已发行和流通股数分别为 17.8 和 17.8	17.8			17.8
资本公积	98.7			105.7
留存收益	1,160.0			1,119.3
累计其他综合损失	(54.4)			(47.1)
股东权益合计	1,222.1			1,195.7
负债和股东权益合计	$	1,459.8			$	1,429.9

随附附注是简明合并财务报表不可分割的组成部分。

ROGERS CORPORATION

简明合并股东权益表

（未经审计）

（金额和股数以百万计）


	截至三个月		截至九个月
	2026年9月30日		2025年9月30日		2026年9月30日		2025年9月30日
股本
期初余额	$	17.9			$	18.1		$	17.8	$	18.5
归属限制性股票单位发行的股份，扣除代扣税款股份	—			—			0.1		—


回购股份	(0.1)			(0.2)			(0.1)		(0.6)
期末余额	17.8			17.9			17.8		17.9
资本公积
期初余额	106.3			126.4			105.7		147.3
归属限制性股票单位发行的股份，扣除代扣税款股份	(1.3)			—			(2.6)		(1.4)
员工购股计划发行的股份	—			—			0.6		0.7

股权薪酬费用	3.0			0.8			7.3		8.7
回购股份（包括消费税）	(9.3)			(9.9)			(12.3)		(38.0)

期末余额	98.7			117.3			98.7		117.3
留存收益
期初余额	1,137.4			1,106.1			1,119.3		1,181.1
净利润（亏损）	22.6			8.6			40.7		(66.4)
期末余额	1,160.0			1,114.7			1,160.0		1,114.7
累计其他综合损失
期初余额	(56.9)			(43.9)			(47.1)		(95.3)
其他综合收益（亏损）	2.5			(3.3)			(7.3)		48.1
期末余额	(54.4)			(47.2)			(54.4)		(47.2)
股东权益合计	$	1,222.1			$	1,202.7		$	1,222.1	$	1,202.7

随附附注是简明合并财务报表不可分割的组成部分。

ROGERS CORPORATION

简明合并现金流量表

（未经审计）

（金额以百万计）


	截至九个月
	2026年9月30日		2025年9月30日
经营活动：
净利润（亏损）	$	40.7			$	(66.4)
将净利润调节为经营活动提供的现金的调整项目：
折旧和摊销	39.9			39.7
股权薪酬费用	7.3			8.7
递延所得税	8.7			(5.2)
减值费用	0.2			71.8
其他非现金费用，净额	(0.5)			1.2
资产和负债变动：
应收账款	(26.2)			(3.9)

合同资产	(1.7)			(1.2)
存货，净额	(6.4)			5.5
其他流动资产	(2.0)			(2.1)
应付账款和其他应计费用	23.7			4.6
其他，净额	(12.1)			1.6
经营活动提供的现金净额	71.6			54.3

投资活动：
资本支出	(16.8)			(25.4)
出售不动产、厂房和设备所得款项，净额	—			13.4
出售可流通权益证券所得款项	0.6			1.0
购买短期投资和可流通权益证券	(30.1)			(0.2)
投资活动所用净现金	(46.3)			(11.2)

融资活动：

支付融资租赁义务款项	(1.3)			(1.2)
支付与股权奖励净额结算相关的税款	(2.6)			(1.4)
员工股票购买计划发行股份所得款项	0.6			0.7
回购股份	(12.3)			(38.1)
融资活动所用净现金	(15.6)			(40.0)

汇率波动对现金的影响	(0.6)			4.9

现金及现金等价物净增加额	9.1			8.0
期初现金及现金等价物	197.0			159.8
期末现金及现金等价物	$	206.1			$	167.8

补充披露：
应计资本性增加	$	2.7			$	3.7
本期支付的现金：
利息（扣除资本化金额）	$	1.2			$	0.9
所得税（扣除退税）	$	17.0			$	16.8

随附附注是简明合并财务报表不可分割的一部分。

ROGERS CORPORATION

简明合并财务报表附注

（未经审计）

附注1 – 列报基础

本文所用“公司”“Rogers”“我们”“本公司”及类似术语，除非上下文另有说明，均指Rogers Corporation及其合并子公司。

随附的未经审计简明合并财务报表依据美国公认会计原则（U.S. GAAP）中期财务信息编制。因此，这些报表未包含完整财务报表所需的全部信息和脚注。我们认为，随附的简明合并财务报表包含了按照美国公认会计原则公允列报所需的所有正常经常性调整。所有公司间余额和交易均已抵销。

中期业绩不一定代表全年业绩。有关我们会计政策的更多信息，请参阅截至2025年12月31日年度的10-K表年度报告（“年度报告”）中所载经审计合并财务报表及其附注。

附注2 – 累计其他综合亏损

累计其他综合亏损各组成部分的变动如下：


（百万美元）	外币折算调整		养老金及其他退休后福利(1)		总计
截至2025年12月31日的余额	$	(39.5)			$	(7.6)		$	(47.1)
重分类前的其他综合亏损	(7.5)			—			(7.5)
从累计其他综合亏损中重分类的金额	—			0.2			0.2
其他综合收益（亏损）	(7.5)			0.2			(7.3)
截至2026年9月30日的余额	$	(47.0)			$	(7.4)		$	(54.4)

截至2024年12月31日的余额	$	(86.7)			$	(8.6)		$	(95.3)
重分类前的其他综合收益	47.9			—			47.9
从累计其他综合亏损中重分类的金额	—			0.2			0.2
其他综合收益	47.9			0.2			48.1
截至2025年9月30日的余额	$	(38.8)			$	(8.4)		$	(47.2)

(1)扣除税款后，截至2026年9月30日和2025年12月31日分别为110万美元和120万美元。截至2025年9月30日和2024年12月31日分别为扣除税款后140万美元和150万美元。

附注3 – 衍生工具与套期保值

以下介绍了用于管理相应风险的衍生品合约的估值方法：

•外币 – 任何外币期权衍生品的公允价值均根据估值模型，结合当前市场信息（如行权价、即期汇率、到期日和波动率）确定，并参考场外市场交易形成的市场价值，或通过获取具有类似特征的类似工具的市场数据确定。

•商品 – 铜衍生品的公允价值采用内在价值和时间价值估值模型组合计算，这些模型共同取决于五个主要变量：标的工具价格、到期时间、行权价、利率和波动率。内在价值估值模型反映期末场外市场中铜衍生品工具的行权价与当前 prevailing 铜价之间的差额。时间价值估值模型纳入了标的铜衍生品工具价格的变动、货币时间价值、标的铜衍生品工具的行权价，以及自期末日起至标的铜衍生品工具到期日的剩余时间。

截至2026年9月 30日，我们没有任何符合套期会计处理条件的衍生品合约。

外币

截至2026年9月30日的九个月内，我们签订了美元和欧元远期合约。签订这些外币远期合约是为了降低某些全球交易风险敞口。这些合约不符合套期会计处理条件。因此，这些合约所需的任何公允价值调整均在调整发生期间计入我们简明合并经营报表中的“其他收入（费用），净额”项目。

截至2026年9月 30日，剩余外币远期合约的名义价值如下：


（金额以百万计）
货币（买入/卖出）	到期日	名义金额（买入/卖出）
USD/CNY	2026年11月3日	$57.9 / ¥390.0
EUR/USD	2026年11月2日	€12.1 / $13.8

商品

截至2026年9月 30日，我们有12份未到期合约，用于对冲AES运营及可报告分部中与铜商品价格相关的风险敞口。这些合约由金融机构持有，旨在抵消铜价上涨，且不符合套期会计处理条件。因此，这些合约所需的任何公允价值调整均在调整发生期间计入我们简明合并经营报表中的“其他收入（费用），净额”项目。

截至2026年9月 30日，我们未到期铜合约的数量如下：


（数量以个计，名义金额以百万计）
合约期间	数量	名义金额
2026年10月 - 2026年12月	每月69公吨	$2.3
2027年1月 - 2027年3月	每月69公吨	$2.7
2027年4月 - 2027年6月	每月69公吨	$2.8
2027年7月 - 2027年9月	每月69公吨	$2.9

对财务报表的影响

下表列示了这些工具对简明合并经营报表和简明合并综合收益（亏损）表的影响：


		截至三个月		截至九个月
（百万美元）	财务报表项目	2026年9月30日		2025年9月30日	2026年9月30日		2025年9月30日
外汇合同
未指定为套期工具的合同	其他收入（费用），净额	$	(0.7)		$	(0.4)		$	(3.0)	$	(0.8)
铜衍生品合同
未指定为套期工具的合同	其他收入（费用），净额	$	0.5		$	—		$	1.0	$	0.1

附注4 - 资产负债表项目

应收账款

简明合并财务状况表中的“应收账款净额”项目包括以下内容：


（百万美元）	2026年9月30日		2025年12月31日
贸易应收账款	$	149.4			$	121.2
信用损失准备	(1.5)			(1.3)
其他应收账款	7.5			10.7
应收账款净额总计	$	155.4			$	130.6

合同资产

我们的合同资产主要与未开票收入有关，即对于被认定为没有替代用途的产品，我们有权获得付款。在这些情况下，收入会在向客户开票之前确认，因为通常在向客户发货时开票。未开票收入计入简明合并财务状况表中的“合同资产”项目。截至2026年9月30日或2025年12月31日，我们均无合同负债。截至2026年9月30日或2025年9月30日止的三个月和九个月期间，任何源自我们与客户合同的合同资产均未确认减值损失。截至2026年9月30日和2025年12月31日，我们按经营分部划分的合同资产如下：


（百万美元）	2026年9月30日		2025年12月31日
先进电子解决方案	$	25.5			$	24.0
弹性材料解决方案	0.1			0.1
其他	3.4			3.8
合同资产总额	$	29.0			$	27.9

短期投资

简明合并财务状况表中的“短期投资”项目包括购买日原始期限超过三个月且少于十二个月、截至2026年9月30日剩余期限为十二个月或以下的定期存款。这些投资所赚取的利息计入简明合并经营报表中的“利息收入净额”项目。所有短期投资均按经常性基础以公允价值计量和入账，并归类为公允价值层级中的第2级。截至2026年9月30日，这些投资的摊余成本和公允价值为$30.3 百万。2025年12月31日没有短期投资。

存货

简明合并财务状况表中的“存货净额”项目包括以下内容：


（百万美元）	2026年9月30日		2025年12月31日
原材料	$	58.8			$	51.9
在制品	39.7			42.3
产成品	32.1			30.8
存货总额	$	130.6			$	125.0

应付账款

简明合并财务状况表中的“应付账款”项目包括以下内容：


（百万美元）	2026年9月30日		2025年12月31日
贸易应付账款	$	59.4			$	41.3
其他应付账款	3.9			1.6
应付账款总额	$	63.3			$	42.9

附注5——租赁

融资租赁

我们的融资租赁主要涉及制造设备。在截至2026年和2025年9月30日的三个月内，以租赁负债换取的融资租赁使用权资产相关非现金活动均为零。在截至2026年和2025年9月30日的九个月内，以租赁负债换取的融资租赁使用权资产相关非现金活动分别为零和810万美元。我们的融资租赁费用和付款如下：


	截至三个月		截至九个月
（百万美元）	2026年9月30日		2025年9月30日	2026年9月30日		2025年9月30日
融资租赁使用权资产摊销费用	$	0.3		$	0.5		$	1.1	$	1.3
融资租赁负债利息费用	$	(0.1)		$	(0.1)		$	(0.3)	$	(0.3)
融资租赁负债付款	$	0.4		$	0.4		$	1.3	$	1.2

经营租赁

我们的经营租赁主要涉及制造和研发设施以及车辆。在截至2026年和2025年9月30日的三个月内，以租赁负债换取的经营租赁使用权资产相关非现金活动均为20万美元。在截至2026年和2025年9月30日的九个月内，以租赁负债换取的经营租赁使用权资产相关非现金活动分别为80万美元和60万美元。我们的经营租赁费用和付款如下：


	截至三个月		截至九个月
（百万美元）	2026年9月30日		2025年9月30日	2026年9月30日		2025年9月30日
经营租赁费用	$	1.2		$	1.6		$	3.7	$	4.5
短期租赁费用	$	0.1		$	0.2		$	0.4	$	0.6
经营租赁负债付款	$	3.5		$	1.2		$	6.2	$	4.0

财务状况表中的租赁余额

简明合并财务状况表中反映的融资租赁和经营租赁相关资产及负债余额如下：


（百万美元）	财务报表项目	2026年9月30日		2025年12月31日
融资租赁使用权资产	不动产、厂房和设备，净额	$	7.2		$	8.6
经营租赁使用权资产	经营租赁使用权资产	$	13.7		$	19.2

融资租赁负债流动部分	其他应计负债	$	1.3		$	1.4
融资租赁负债非流动部分	其他长期负债	$	6.2		$	7.4
融资租赁负债总额		$	7.5		$	8.8

经营租赁负债流动部分	经营租赁负债流动部分	$	3.4		$	3.9
经营租赁义务，非流动部分	经营租赁义务，非流动部分	$	10.8		$	17.9
经营租赁义务总额		$	14.2		$	21.8

未来最低租赁付款净额

下表列示了截至2026年9月30日融资租赁和经营租赁项下的未来最低租赁付款，以及未来最低租赁付款净额的现值：


	融资		经营
（百万美元）	生效中的租赁		生效中的租赁
2026	$	0.4			$	1.3
2027	1.5			3.8
2028	1.4			2.7
2029	1.3			2.5
2030	1.3			2.3
此后	2.7			3.8
租赁付款总额	8.6			16.4
减：利息	(1.1)			(2.2)
未来最低租赁付款现值	$	7.5			$	14.2

截至2026年9月30日，没有已签署且未来开始生效的重大租赁。

下表列示了用于计算未来最低租赁付款净额现值的租赁期限和折现率信息：


	2026年9月30日	2025年12月31日
加权平均剩余租赁期限
融资租赁	6.1年	6.7年
经营租赁	5.3年	6.4年
加权平均折现率
融资租赁	4.63%	4.70%
经营租赁	5.24%	5.55%

2026年7月13日，公司与房东就我们在墨西哥的租赁设施签订了一份和解协议。根据该协议，我们支付了260万美元的和解款以终止租赁。由于该和解，账面价值各为350万美元的剩余使用权资产和租赁负债于2026年第三季度终止确认。

附注6——商誉和无形资产

商誉

各经营分部商誉账面净值的变动如下：


（百万美元）	先进电子解决方案		弹性体材料解决方案		其他		总计
2025年12月31日	$	51.7			$	249.5		$	2.2	$	303.4



外币折算调整	—			(0.4)			—		(0.4)
2026年9月30日	$	51.7			$	249.1		$	2.2	$	303.0

无形资产

无形资产的账面金额如下：


	2026年9月30日		2025年12月31日
（百万美元）	账面总额			累计摊销		账面净额		账面总额	累计减值		累计摊销	账面净额
客户关系	$	180.1				$	110.8		$	69.3		$	180.9		$	—		$	105.6	$	75.3
技术	78.5				68.4			10.1		79.4		—		67.2			12.2
商标和商品名称	20.0				8.7			11.3		20.1		—		8.3			11.8
有限寿命无形资产总额	278.6				187.9			90.7		280.4		—		181.1			99.3
无限寿命无形资产	—				—			—		4.5		4.5		—			—
无形资产总额	$	278.6				$	187.9		$	90.7		$	284.9		$	4.5		$	181.1	$	99.3

上表中的账面总额和累计摊销可能因汇率波动而与以前期间不同。

无形资产相关的摊销费用如下：


	截至三个月		截至九个月
（百万美元）	2026年9月30日		2025年9月30日	2026年9月30日		2025年9月30日
摊销费用	$	2.7		$	2.8		$	8.0	$	8.2

预计未来摊销费用分别为2026年的2.7 million、2027年的10.2 million、2028年的8.0 million、2029年的7.5 million和2030年的7.1 million。这些金额可能会因外币汇率变动而有所不同。

截至2026年9月 30日，各类无形资产的加权平均摊销期限如下表所示：


		加权平均剩余摊销期限
客户关系		6.4年
技术		2.5年
商标和商品名称		8.2年

无形资产总额		6.2年

附注7 – 退休后福利计划

养老金计划

截至2026年9月 30日，我们有一项合格的非缴费型设定受益养老金计划，即Union Plan，该计划已于2013年冻结并停止累计福利。各计划年度的计量日为12月31日st。我们无需在2025年向Union Plan缴款，且2026年也无需缴款。

递延薪酬计划

我们设有一项非合格递延薪酬计划，为特定的部分精选员工提供规定的递延薪酬福利。递延薪酬计划通过拉比信托提供资金，最终根据各计划参与者从预先批准的基金中所作的选择进行投资。截至2026年9月 30日，我们的递延薪酬计划主要由有价证券（包括共同基金）构成。截至2025年12月 31日，我们的递延薪酬计划主要由有价证券（包括共同基金和固定收益基金）构成。有价证券按公允价值入账。相关余额列示于简明合并财务状况表中的“其他长期资产”项目。下表按主要证券类型汇总了我们按经常性基础以公允价值计量并按公允价值层级分类的有价证券：


	截至2026年9月 30日递延薪酬计划的公允价值
（百万美元）	调整后成本		未实现收益	未实现损失		公允价值
第1级证券：
共同基金	$	4.3		$	0.5		$	—	$	4.8


总计	$	4.3		$	0.5		$	—	$	4.8


	截至2025年12月 31日递延薪酬计划的公允价值
（百万美元）	调整后成本		未实现收益	未实现损失		公允价值
第1级证券：
共同基金	$	4.1		$	0.7		$	(0.1)	$	4.7
第2级证券：
固定收益基金	$	0.1		$	—		$	—	$	0.1
总计	$	4.2		$	0.7		$	(0.1)	$	4.8

附注8 – 循环信贷额度

2023年3月24日，公司签订了第五次修订及重述信贷协议，该协议提供4.500亿美元循环信贷额度，并设有最高可增加2.250亿美元的扩容选项，到期日为2028年3月24日。第五次修订及重述信贷协议的主要条款见公司年度报告所载合并财务报表附注9。截至2026年9月30日止三个月和九个月期间，信贷协议条款没有重大变化。

截至2026年9月30日和2025年12月31日，公司在循环信贷额度项下均无未偿借款，且遵守所有财务及非财务契约。

附注9——承诺与或有事项

我们目前涉及以下重大法律和环境诉讼：

石棉

概述

与许多其他工业公司一样，我们在全国各地法院提起的多起诉讼中被列为被告，原告声称因接触含石棉产品而遭受人身伤害。我们从未开采、加工、制造或销售石棉；相反，我们曾向工业用户制造并提供少量含有封装石棉的产品，但在20世纪80年代末停止制造这些产品。针对我们的多数索赔涉及多名被告，有时多达数百名。在几乎所有针对我们的案件中，原告均向多名被告索赔超过管辖权最低限额但金额未明确的损害赔偿；这些被告可能制造、销售或使用了原告据称曾接触并因此据称遭受伤害的含石棉产品。大多数案件正在马里兰州、伊利诺伊州、密苏里州和纽约州审理；不过，我们也在其他州应诉。我们继续积极为这些案件辩护，主要依据是原告无法证明因接触我们的产品而遭受可获赔偿的损失。迄今为止，我们与石棉相关产品责任诉讼的赔偿和辩护费用已基本由保险承保。

下表汇总了截至2026年9月30日的九个月内未结石棉索赔数量的变动：


	石棉索赔
截至2026年1月1日的未结索赔	442
新提起的索赔	129
驳回的待决索赔	(155)
已和解的待决索赔	(11)
截至2026年 9月30日的未结索赔	405

2026年石棉索赔的赔偿和解金额如下：


（金额单位：百万美元）	2026年9月30日
和解金额	$	5.2

对财务报表的影响

对于很可能发生且能够合理估计的石棉相关或有事项，我们确认负债。在确认石棉相关事项负债时，我们会记录被认为很可能收回的石棉相关保险赔款。

负债预测期涵盖截至2064年的所有当前及未来赔偿和辩护费用；预计我们的石棉责任风险届时终止，之后不再有持续索赔。此结论依据我们对索赔数据的历史记录和经验、可观察索赔数据波动性的降低及其一致性、我们停止制造含有封装石棉产品以来已过去的时间，以及索赔数量预计将呈下降趋势；这是由于索赔人平均年龄已接近平均预期寿命。

迄今，与石棉相关的产品责任诉讼赔偿及辩护费用已基本由保险承保。尽管我们已用尽某些保险单的承保额度，但我们认为，对于制造和销售含石棉产品的大多数年份所引发的索赔，我们均拥有适用的主保险、超额保险和/或伞式保险。此外，我们已与大多数主保险、超额保险和伞式保险承保人签订成本分摊协议，以便持续管理和支付承保人承保的索赔。任何一方均可终止成本分摊协议，但在任何一方选择终止前，协议将继续有效。截至本报告提交日，该协议尚未终止，也没有承保人告知我们其有意终止协议。我们预计，随着时间推移，个别主保险、超额保险和伞式保险的承保额度将持续耗尽；但无法保证新增索赔、损害赔偿和和解不会加速额度耗尽，也无法保证承保范围会如预期般可用。

已记录的石棉相关负债及相关保险应收款金额，依据当时已知事实和若干假设确定。然而，对未来事件的预测，例如每年提交的新索赔数量、处理此类索赔的平均成本、处理所需时间、保险人之间的承保问题以及各保险公司的持续偿付能力，再加上美国石棉诉讼所涉及的诸多不确定因素，可能导致我们的实际负债和保险赔付高于或低于预测或已记录金额。我们因石棉相关诉讼所面临的财务风险全部范围仍极难估计，可能包括补偿性和惩罚性损害赔偿裁决。

根据对石棉诉讼及相应保险承保范围的预测而记录的估计负债和估计保险赔款变动，将导致确认费用或收入。

我们预计的石棉相关负债和保险应收款如下：


（百万美元）	2026年9月30日		2025年12月31日
石棉相关负债	$	56.9		$	57.4
石棉相关保险应收款	$	52.8		$	52.8

环境自愿纠正行动计划

我们位于康涅狄格州罗杰斯的地点属于康涅狄格州自愿纠正行动计划的一部分。作为该计划的一环，我们与康涅狄格州能源与环境保护部合作，确定针对该场地污染问题应采取的纠正措施。我们评估了此事，并于2015年完成了与该场地相关的内部尽职调查工作。该场地的修复工作仍在进行中，相关费用在发生时冲减应计负债。截至2026年9月30日，我们累计发生200万美元的修复成本，其中绝大部分在2023年前发生并计提；未来修复工作的应计负债为70万美元。

其他事项

除上述问题外，我们业务的性质和范围使我们经常与公众以及各类企业和政府机构接触。这些活动使我们不可避免地面临诉讼风险，包括在日常经营过程中进行抗辩和处理的环境及产品责任事项。对于管理层认为很可能发生且能够合理估计损失的事项，我们已计提应计款项。管理层认为，截至目前所知事实表明，此类诉讼不会对我们的经营业绩、财务状况或现金流产生重大不利影响。

注释 10 – 每股收益（亏损）

基本每股收益（亏损）以加权平均已发行普通股数为基础。稀释每股收益（亏损）以加权平均已发行普通股数及所有具有稀释性的潜在已发行普通股数为基础。

下表列示了基本和稀释每股收益（亏损）的计算：


（金额和股数以百万计，每股金额除外）	截至三个月		截至九个月
2026 年 9 月 30 日		2025 年 9 月 30 日		2026 年 9 月 30 日		2025 年 9 月 30 日
分子：
净收入（亏损）	$	22.6			$	8.6		$	40.7	$	(66.4)
分母：
加权平均已发行股数——基本	17.8			18.1			17.8		18.3
稀释性股份的影响	0.1			—			0.1		—
加权平均已发行股数——稀释	17.9			18.1			17.9		18.3
基本每股收益（亏损）	$	1.27			$	0.48		$	2.29	$	(3.63)
稀释每股收益（亏损）	$	1.26			$	0.48		$	2.27	$	(3.63)

稀释性股份采用库存股法计算，主要包括未归属的限制性股票单位。计算稀释股数和稀释每股收益时，不包括反稀释股份。截至 2026 年 9 月 30 日止三个月和九个月期间，计算稀释每股收益时排除的股份数量并不重大。

截至 2025 年 9 月 30 日止九个月期间，假设限制性股票单位归属会对稀释每股亏损产生反稀释影响，因此未计入稀释每股亏损的计算。截至 2025 年 9 月 30 日止九个月期间，计算稀释每股亏损时排除了 0.2 百万股反稀释股份。

注释 11 – 股本和股权薪酬

股份回购

2015年，我们启动了一项股份回购计划（以下简称“计划”），回购金额最高为1亿美元的公司股本，以减轻公司授予的股票期权行权和限制性股票单位归属所产生的稀释影响，并提升股东价值。2024年，董事会批准额外拨款1亿美元用于股份回购。该计划没有到期日，可随时暂停或终止，恕不另行通知。截至2026年9月30日的三个月内，我们回购了73,448股，购买总价为930万美元，资金来自经营活动产生的现金和手头现金。截至2026年9月30日的九个月内，我们回购了96,066股，购买总价为1,230万美元，资金来自经营活动产生的现金和手头现金。截至2026年9月30日，该计划下仍有3,950万美元可用于回购。我们的股票回购可能不时通过公开市场购买、私下协商交易或旨在遵守《交易法》颁布的第10b5-1条规则的计划进行。

股权薪酬

股权薪酬费用

股权薪酬费用的构成如下：


	截至以下日期的三个月		截至以下日期的九个月
（百万美元）	2026年9月30日		2025年9月30日		2026年9月30日		2025年9月30日
基于业绩的限制性股票单位费用	$	1.1			$	(0.7)		$	1.7	$	3.2
基于时间的限制性股票单位费用	1.3			1.1			4.1		4.6
递延股票单位费用	0.5			0.4			1.2		0.6
其他	0.1			—			0.3		0.3
股权薪酬费用总额	$	3.0			$	0.8		$	7.3	$	8.7

基于业绩的限制性股票单位

截至2026年9月30日，我们尚有2026年、2025年和2024年授予的、附带市场条件的未归属基于业绩的限制性股票单位。这些奖励通常在三年计量期结束时一次性归属。但是，若员工在计量期内因死亡、残疾或在某些情况下因退休而离职，则可能根据其在计量期内受雇的天数按比例获得奖励。根据某些既定绩效指标，参与者有资格获得原奖励数量0%至200%的股份。

附带市场条件的基于业绩的限制性股票单位有一项计量标准：我们股本的三年股东总回报率与指定同业公司群体的股东总回报率相比。该计量标准的公允价值在授予日使用蒙特卡洛模拟估值模型确定。我们在归属期内以直线法确认所有这些奖励的薪酬费用，不因最终预计的奖励支付额而作调整。没收在实际发生时进行会计处理。

下表列出了2026年和2025年授予的各项重大奖励在蒙特卡洛计算中使用的假设：


	2026年5月19日	2026年2月18日	2026年2月12日	2025年2月26日
预期波动率	36.5%	34.7%	34.6%	45.6%
预期期限（年）	2.6年	2.9年	2.9年	2.9年
无风险利率	4.10%	3.44%	3.43%	4.28%

预期波动率 – 在确定预期波动率时，我们考虑了多项因素，包括历史波动率。

预期期限 – 我们使用奖励的归属期来确定蒙特卡洛模拟估值模型中的预期期限假设。

无风险利率 – 我们使用授予日美国国债固定期限利率的隐含“即期利率”收益率，作为无风险利率假设。

预期股息收益率 – 我们目前不对股本支付股息；因此，蒙特卡洛模拟估值模型中使用的股息收益率为 0%。

截至 September 30, 2026，我们有 2026 年授予的尚未结清的、附有财务业绩条件的绩效型限制性股票单位。这些奖励的业绩期为三年，覆盖 January 1, 2026 至 December 31, 2028，通常在业绩期结束后归属（如有）。若员工在业绩期内因死亡、残疾或在某些情况下因符合条件的退休而离职，则可能有资格按其在业绩期内受雇天数的比例获得支付。

附有财务业绩条件的绩效型限制性股票单位有一项业绩标准：在三年业绩期内衡量的年度净销售额增长，最终支付额根据每年达到的平均支付水平确定。这些奖励的公允价值按授予日公司普通股的市场价值确定，并根据每个报告期末估计支付比例的变化，对截至目前确认的累计薪酬费用进行调整。截至 September 30, 2026，该业绩条件被认为很可能实现。因此，薪酬费用已按此估计支付水平确认。公司在发生没收时进行会计处理。

以下列示截至 September 30, 2026 的九个月内尚未结清的绩效型限制性股票单位活动摘要：


	绩效型限制性股票单位
截至 December 31, 2025 尚未结清的奖励	109,916
授予的奖励	53,522
已发行股票	—
没收/取消的奖励	(64,194)
截至 September 30, 2026 尚未结清的奖励	99,244

基于时间的限制性股票单位

截至 September 30, 2026，我们有 2026、2025 和 2024 年授予的尚未结清的基于时间的限制性股票单位奖励。所有尚未结清的奖励均在原始授予日的第一、第二和第三个周年日按比例归属。但是，若员工在计量期内因死亡、残疾或在某些情况下因退休而离职，则可能按其在上一个授予周年日之后的受雇天数比例获得支付。每个基于时间的限制性股票单位代表在归属期结束时获得一股 Rogers 股本的权利。奖励的公允价值按授予日标的股票价格的市场价值确定。我们在归属期内以直线法确认所有这些奖励的薪酬费用。我们在发生没收时进行会计处理。

截至2026年9月30日的九个月内，尚未结清的基于时间归属的限制性股票单位活动摘要如下：


	基于时间归属的限制性股票单位
截至2025年12月31日尚未结清的奖励	115,905
授予的奖励	78,129
已发行股票	(62,618)
已没收/取消的奖励	(23,601)
截至2026年9月30日尚未结清的奖励	107,815

递延股票单位

我们向非管理层董事授予递延股票单位。此类奖励将在授予日一周年时归属，但须持续任职。每个递延股票单位对应发行一股 Rogers 普通股。递延股票单位通常每年在第二季度授予。奖励的公允价值按授予日相关股票的市场价格确定。

截至2026年9月30日的九个月内，尚未结清的递延股票单位活动摘要如下：


	递延股票单位
截至2025年12月31日尚未结清的奖励	23,566
授予的奖励	12,843
已发行股票	(22,616)
截至2026年9月30日尚未结清的奖励	13,793

附注12——分部信息

我们的报告架构由以下战略经营分部和报告分部组成：AES 和 EMS。其余业务为非核心业务，列报于“其他”经营分部。该架构使我们的对外报告形式与目前内部管理和看待业务的方式保持一致。我们的 CODM 是 Rogers Corporation 的首席执行官。CODM 使用毛利率作为报告的分部损益指标来评估各业务分部的表现，并据此决定资源分配以及评估各分部的财务表现，同时考虑收入、库存以及该分部特有的重大费用等因素。

我们的 AES 经营分部和报告分部设计、开发、制造并销售电路材料、陶瓷基板材料、汇流排和冷却解决方案，应用于汽车（例如 ADAS）、航空航天与国防（例如天线系统、通信系统和相控阵雷达系统）、可再生能源（例如风能和太阳能）、无线基础设施（例如功率放大器、天线和小型蜂窝基站）、轨道交通、工业（例如变频驱动器）、互联设备（例如移动互联网设备和热管理解决方案）以及有线基础设施（例如计算和互联网协议基础设施）市场。

我们的 EMS 运营及可报告分部设计、开发、制造并销售工程材料解决方案，适用于各种应用和终端市场。这些解决方案包括用于缓冲、垫片与密封以及振动管理应用的聚氨酯和硅胶材料；用于柔性加热器和半导体热管理应用的定制硅胶；以及用于电线电缆防护、电气绝缘、导电与屏蔽、软管和皮带防护、振动管理、缓冲、垫片与密封以及通风应用的聚四氟乙烯和超高分子量聚乙烯材料。这些产品共同服务于通用工业、便携式电子产品、汽车、大众交通、航空航天与国防、鞋类与冲击缓解以及医疗市场的客户。

我们的其他运营分部包括用于通用工业市场应用的弹性体组件，以及用于通用工业和汽车市场中燃油箱、电机和储罐液位传感应用的弹性体浮子。

分部信息

下表列示了所示期间客户合同收入的分类及其他相关财务信息；净销售额数据已剔除分部间销售：


（百万美元）	先进电子解决方案		弹性体材料解决方案		其他		总计
截至2026年9月 30日的三个月
净销售额——随时间确认	$	44.1			$	1.2		$	4.0	$	49.3
净销售额——于某一时点确认	86.1			100.2			0.5		186.8
净销售额总额	$	130.2			$	101.4		$	4.5	$	236.1
销售成本	$	89.9			$	62.5		$	3.0	$	155.4
毛利	$	40.3			$	38.9		$	1.5	$	80.7

存货净额	$	78.3			$	50.4		$	1.9	$	130.6
折旧费用	$	5.3			$	2.7		$	0.2	$	8.2

截至2025年9月 30日的三个月
净销售额——随时间确认	$	47.7			$	2.2		$	3.8	$	53.7
净销售额——于某一时点确认	67.0			95.0			0.3		162.3
净销售额总额	$	114.7			$	97.2		$	4.1	$	216.0
销售成本	$	78.6			$	62.5		$	2.6	$	143.7
毛利	$	36.1			$	34.7		$	1.5	$	72.3

存货净额	$	85.7			$	55.5		$	1.7	$	142.9
折旧费用	$	4.4			$	2.9		$	0.2	$	7.5

截至2026年9月 30日的九个月
净销售额——随时间确认	$	126.3			$	4.5		$	11.9	$	142.7
净销售额——于某一时点确认	229.1			280.1			1.5		510.7
净销售额总额	$	355.4			$	284.6		$	13.4	$	653.4
销售成本	$	250.2			$	179.4		$	8.1	$	437.7
毛利	$	105.2			$	105.2		$	5.3	$	215.7

存货净额	$	78.3			$	50.4		$	1.9	$	130.6
折旧费用	$	16.2			$	8.1		$	0.6	$	24.9

截至2025年9月 30日的九个月
净销售额——随时间确认	$	121.5			$	6.7		$	11.2	$	139.4
净销售额——于某一时点确认	206.4			262.5			1.0		469.9
净销售额总额	$	327.9			$	269.2		$	12.2	$	609.3
销售成本	$	231.8			$	176.3		$	7.9	$	416.0
毛利	$	96.1			$	92.9		$	4.3	$	193.3

存货净额	$	85.7			$	55.5		$	1.7	$	142.9
折旧费用	$	13.0			$	8.5		$	0.6	$	22.1

按地理区域划分的分部净销售额

下表列示了所示期间各分部运营按地理区域划分的净销售额：


（百万美元）	净销售额(1)
地区/国家	先进电子解决方案		弹性体材料解决方案		其他		总计
截至2026年9月 30日的三个月
美国	$	24.3			$	40.5		$	1.3	$	66.1
美洲其他地区	0.8			2.5			(0.1)		3.2
美洲合计	25.1			43.0			1.2		69.3
中国	47.0			28.2			1.3		76.5
亚太其他地区	12.8			9.0			0.6		22.4
亚太合计	59.8			37.2			1.9		98.9
德国	15.0			5.9			0.2		21.1
欧洲、中东和非洲其他地区	30.3			15.3			1.2		46.8
欧洲、中东和非洲合计	45.3			21.2			1.4		67.9
净销售额总额	$	130.2			$	101.4		$	4.5	$	236.1
截至2025年9月 30日的三个月
United States	$	22.4			$	38.0		$	0.8	$	61.2
Other Americas	0.5			3.7			0.1		4.3
Total Americas	22.9			41.7			0.9		65.5
China	38.0			29.3			1.4		68.7
Other APAC	11.0			8.7			0.3		20.0
Total APAC	49.0			38.0			1.7		88.7
Germany	14.3			5.4			0.1		19.8
Other EMEA	28.5			12.1			1.4		42.0
Total EMEA	42.8			17.5			1.5		61.8
Total net sales	$	114.7			$	97.2		$	4.1	$	216.0

(1)Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated.


(Dollars in millions)	Net Sales(1)
Region/Country	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Nine Months Ended September 30, 2026
United States	$	62.4			$	112.1		$	3.2	$	177.7
Other Americas	3.4			9.6			—		13.0
Total Americas	65.8			121.7			3.2		190.7
China	130.0			73.0			4.5		207.5
Other APAC	41.2			25.9			1.3		68.4
Total APAC	171.2			98.9			5.8		275.9
Germany	42.1			19.5			0.6		62.2
Other EMEA	76.3			44.5			3.8		124.6
Total EMEA	118.4			64.0			4.4		186.8
Total net sales	$	355.4			$	284.6		$	13.4	$	653.4
Nine Months Ended September 30, 2025
United States	$	67.4			$	105.6		$	2.5	$	175.5
Other Americas	1.7			9.4			0.1		11.2
Total Americas	69.1			115.0			2.6		186.7
China	105.5			75.1			3.7		184.3
Other APAC	37.2			24.4			1.5		63.1
Total APAC	142.7			99.5			5.2		247.4
Germany	39.3			16.9			0.5		56.7
Other EMEA	76.8			37.8			3.9		118.5
Total EMEA	116.1			54.7			4.4		175.2
Total net sales	$	327.9			$	269.2		$	12.2	$	609.3

(1)Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated.

Note 13 – Supplemental Financial Information

Restructuring, Asset Impairment, and Other Charges

The components of the “Restructuring, asset impairment, and other charges” line item in the condensed consolidated statements of operations were as follows:


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Restructuring charges
Manufacturing footprint consolidation	$	0.8			$	1.3		$	5.8	$	8.9
Global workforce reduction	0.2			0.4			0.8		2.9
Executive leadership transition	—			5.4			0.8		5.4
Other	—			—			—		0.1
Total restructuring charges	1.0			7.1			7.4		17.3
Impairment charges
Lease impairment charges	—			—			0.2		—

Goodwill impairment	—			—			—		67.3
Other intangible assets impairment	—			—			—		4.5
Total impairment charges	—			—			0.2		71.8
Total restructuring, asset impairment, and other charges	$	1.0			$	7.1		$	7.6	$	89.1

Restructuring Charges - Manufacturing Footprint Consolidation

In June 2024, we announced our intent to consolidate our high frequency circuit material manufacturing operations, impacting our Evergem, Belgium facility, which was completed in the fourth quarter of 2025. We incurred $1.3 million in restructuring charges in the three months ended September 30, 2025, substantially all of which were related to severance and other termination benefits.

In July 2025, we announced our intention to implement initiatives to reduce costs in the curamik® business under our AES operating and reportable segment and expect to record expenses in the range of $12.0 million to $15.0 million comprised of severance costs, property, plant and equipment relocation and reinstallation costs, consulting fees and other miscellaneous cash costs.

During the three and nine months ended September 30, 2026, we recognized $0.8 million and $5.8 million, respectively, in restructuring charges, nearly all of which relate to severance and termination benefits.

Restructuring Charges - Global Workforce Reduction

We incurred $0.2 million and $0.4 million in pre-tax restructuring charges related to the global workforce reduction for the three months ended September 30, 2026 and 2025, respectively, and $0.8 million and $2.9 million in pre-tax restructuring charges related to this plan for the nine months ended September 30, 2026 and 2025, respectively, all of which were related to severance and other termination benefits.

Restructuring Charges - Executive Leadership Transition

In July 2025, certain executives left the Company as part of an executive leadership transition. In addition to these departures, other related organizational changes were made leading to departures of additional personnel through March 2026. We have incurred $0.8 million in restructuring charges related to this transition in the nine months ended September 30, 2026 for severance and other termination benefits.

Restructuring Severance and Related Benefits Accrual

Remaining severance and related benefits to be paid for the manufacturing footprint consolidation, global workforce reduction, and executive leadership transition restructuring projects is presented in the table below for the period ended September 30, 2026:


(Dollars in millions)	Restructuring Severance and Related Benefits
Balance as of December 31, 2025	$	10.2
Provisions	7.3
Payments	(14.8)
Foreign currency translation adjustment	(0.1)
Balance as of September 30, 2026	$	2.6

Allocation of Restructuring, Asset Impairment, and Other Charges to Operating and Reportable Segments

The following table summarizes the allocation of restructuring, asset impairment, and other charges to our operating and reportable segments:


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Advanced Electronics Solutions
Allocated restructuring charges	$	1.0			$	4.2		$	6.9	$	12.7
Allocated impairment charges	—			—			0.2		71.8
Elastomeric Material Solutions
Allocated restructuring charges	—			2.9			0.5		4.6

Total restructuring, asset impairment, and other charges	$	1.0			$	7.1		$	7.6	$	89.1

Other Income (Expense), Net

The components of the “Other income (expense), net” line item in the condensed consolidated statements of operations, were as follows:


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Foreign currency translation impacts	$	0.4			$	0.8		$	3.6	$	(2.4)
Foreign currency derivative impacts	(0.7)			(0.4)			(3.0)		(0.8)
Copper derivative impacts	0.5			—			1.0		0.1

Other	0.1			—			0.1		(0.3)
Total other income (expense), net	$	0.3			$	0.4		$	1.7	$	(3.4)

Interest Income, Net

The components of the “Interest income, net” line item in the condensed consolidated statements of operations, were as follows:


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025

Line of credit fees	$	(0.3)			$	(0.3)		$	(0.9)	$	(0.9)
Debt issuance amortization costs	(0.2)			(0.2)			(0.4)		(0.4)
Interest income	1.1			0.7			2.8		2.3
Other	—			—			(0.3)		(0.1)
Total interest income, net	$	0.6			$	0.2		$	1.2	$	0.9

Note 14 – Income Taxes

Compared to the 21% U.S. statutory federal corporate income tax rate, we had a tax rate of 27.1% in the third quarter of 2026. During the quarter, our effective tax rate was unfavorably impacted by an increase in the valuation allowance attributable to loss jurisdictions in which no tax benefit is anticipated to be realized.

We had a tax rate of 47.2% in the third quarter of 2025. During such quarter, our effective tax rate was unfavorably impacted by (i) an increase in the valuation allowance attributable to loss jurisdictions in which no tax benefit is anticipated to be realized and (ii) an increase in reserves for uncertain tax positions.

We had a tax rate of 36.1% for the nine months ended September 30, 2026. The effective rate for the first nine months of 2026 was unfavorably impacted by an increase in the valuation allowance attributable to loss jurisdictions in which no tax benefit is anticipated to be realized.

We had a negative tax rate of 21.6% for the nine months ended September 30, 2025 due to tax expense on a pre-tax book loss. Our income tax expense for the nine months ended September 30, 2025 was unfavorably impacted by the $67.3 million goodwill impairment in curamik® for which no tax benefit is available, an increase in the valuation allowance attributable to loss jurisdictions in which no tax benefit is anticipated to be realized, and an increase in reserves for uncertain tax positions.

Note 15 - Recent Accounting Standards

Recently Adopted Standards

In July 2025, the FASB issued ASU 2025‑05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets for Private Companies and Certain Not‑for‑Profit Entities (Subtopic 326‑20). The amendments in this update provide a practical expedient allowing eligible entities to measure expected credit losses on current trade receivables and contract assets using an aging method, rather than developing a full CECL model. The ASU is effective for fiscal years beginning after December 15, 2025, with early adoption permitted. Adoption should be applied prospectively to financial statements issued after the effective date, or retrospectively to any or all prior periods presented. The updated guidance has not had an impact on how we calculate our allowance for credit losses.

Recently Issued Standards

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require new disclosures in tabular format, disaggregating information about prescribed categories underlying any relevant income statement expense captions. The ASU is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. Adoption should be applied either prospectively to financial statements issued after the effective date, or retrospectively to any or all prior periods presented in the

financial statements. We anticipate adopting ASU 2024-03 in our Annual Report on Form 10-K for the year ending December 31, 2027, using a prospective transition method. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other Internal-Use Software (Subtopic 350-40). This update specifically targets improvements to the accounting for internal-use software. The amendments in this update (1) remove all references to prescriptive and sequential software development stages throughout Subtopic 350-40, (2) specify that the disclosures in Subtopic 360-10 are required for all capitalized internal-use software costs, regardless of how those costs are presented in the financial statements, (3) clarify that the intangibles disclosures in paragraphs 350-30-50-1 through 50-3 are not required for capitalized internal-use software costs, and (4) supersede the website development costs guidance and incorporate the recognition requirements for website-specific development costs from Subtopic 350-50 into Subtopic 350-40. The ASU is effective for fiscal years beginning after December 15, 2027, and interim periods within those annual reporting periods, with early adoption permitted. Adoption should be applied either prospectively to financial statements issued after the effective date, a modified approach that is based on the status of the project and whether software costs were capitalized before the date of adoption, or retrospectively to any or all prior periods presented in the financial statements. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Position

As used herein, the “Company,” “Rogers,” “we,” “us,” “our” and similar terms include Rogers Corporation and its subsidiaries, unless the context indicates otherwise.

Forward-Looking Statements

This Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Such statements are generally accompanied by words such as “anticipate,” “assume,” “believe,” “could,” “estimate,” “expect,” “foresee,” “goal,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “seek,” “target” or similar expressions that convey uncertainty as to future events or outcomes. Forward-looking statements are based on assumptions and beliefs that we believe to be reasonable; however, assumed facts almost always vary from actual results, and the differences between assumed facts and actual results could be material depending upon the circumstances. Where we express an expectation or belief as to future results, that expectation or belief is expressed in good faith and based on assumptions believed to have a reasonable basis. We cannot assure you, however, that the stated expectation or belief will occur or be achieved or accomplished. Among the factors that could cause our results to differ materially from those indicated by forward-looking statements are risks and uncertainties inherent in our business including, without limitation:

•failure to capitalize on, volatility within, or other adverse changes with respect to growth opportunities, such as delays in adoption or implementation of new technologies;

•our ability to realize the anticipated benefits of our cost reduction, restructuring, manufacturing and site consolidation and operational excellence initiatives;

•uncertain business, economic and political conditions in the U.S. and abroad, particularly in China, Germany, England, Belgium, South Korea, and Hungary where we maintain significant manufacturing, sales or administrative operations;

•the global trade policy dynamics between nations reflected in trade agreement negotiations, the imposition of tariffs and other trade restrictions, as well as the potential for global supply chain decoupling;

•fluctuations in foreign currency exchange rates;

•our ability to develop innovative products and the extent to which they are incorporated into end-user products and systems that achieve commercial success;

•the ability and willingness of our sole or limited source suppliers to deliver certain key raw materials, including commodities, to us in a timely and cost-effective manner;

•business interruptions due to catastrophes, geopolitical events, or other similar events, such as natural disasters, war, terrorism, or public health crises;

•the impact of sanctions, export controls and other foreign asset or investment restriction;

•failure to realize, or delays in the realization of, anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses;

•our ability to attract and retain management and skilled technical personnel;

•our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third-party rights;

•changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate;

•failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants;

•the outcome of ongoing and future litigation, including our asbestos-related product liability litigation;

•changes in environmental laws and regulations applicable to our business; and

•disruptions in, or breaches of, our information technology systems.

Our forward-looking statements are expressly qualified by these cautionary statements, which you should consider carefully, along with the risks discussed in this section and elsewhere in this report in addition to the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”) and our other reports filed with the SEC, any of which could cause actual results to differ materially from historical results or anticipated results. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

The following discussion and analysis of our financial condition and results of operations should be read together with our condensed consolidated financial statements and the related notes that appear elsewhere in this Form 10-Q along with our audited consolidated financial statements and the related notes thereto in our Annual Report.

Company Overview

We design, develop, manufacture, and sell high-performance, high-reliability engineered materials and components that help customers solve complex challenges in connectivity, thermal management, power electronics, system protection, and other areas. We operate in two reportable segments: AES and EMS. Our remaining non-core operations are reported in our Other operating segment. We are headquartered in Chandler, Arizona.

Our strategy is to build a high-growth, high-performing company by strengthening our positions in attractive core markets and extending proven technologies and manufacturing capabilities into compelling adjacent opportunities.

Our core end markets include industrial, automotive, aerospace and defense, electronics, and communications. Demand in these markets is supported by market trends including aerospace and defense investment, electrification, higher levels of vehicle safety, factory automation, supply chain regionalization, and increasing demand for premium electronic devices.

Our targeted high-growth adjacent opportunities include AI data centers, advanced battery systems, and electromagnetic interference shielding, where we are leveraging established products, applications expertise, manufacturing capabilities, and customer relationships to address evolving performance requirements.

Our sales, applications engineering and technical service teams work closely with customers throughout the development process to understand system-level challenges and develop customized solutions. This customer-focused model, together with our broad product portfolio, global manufacturing footprint, regional technical support, and reputation for mission-critical reliability, supports strong customer relationships and our growth plans.

We are operating with greater focus and accountability to make faster decisions, shorten development cycles, and respond more quickly to customer needs. Our operational improvement initiatives include improving quality, yields, and throughput; strengthening procurement and supplier strategies; advancing continuous improvement; and maintaining a scalable cost structure.

We intend to continue investing in innovation, technical capabilities, and manufacturing capacity in a disciplined manner, while preserving financial flexibility and allocating capital to opportunities that we believe offer attractive risk-adjusted returns and create long-term shareholder value.

If we successfully execute this strategy, we believe we can increase annual revenues through a combination of growth in our core markets and targeted high-growth adjacent opportunities. We expect organic growth to be the primary driver, with the potential to be supplemented by disciplined acquisitions that add capabilities, strengthen market positions, or accelerate our strategic priorities. Achieving this revenue growth is also expected to result in higher profitability and earnings.

Executive Summary

The following factors should be considered when reviewing our results of operations, financial position, and liquidity:

•In the third quarter of 2026 as compared to the third quarter of 2025, our net sales increased approximately 9.3% to $236.1 million, our gross margin increased approximately 70 basis points to 34.2% from 33.5%, and we had an operating margin of 12.7% compared to an operating margin of 7.3%.

•We repurchased 73.4 thousand shares of our capital stock for $9.3 million in the third quarter of 2026.

Results of Operations

The following table sets forth, for the periods indicated, selected operations data expressed as a percentage of net sales:


	Three Months Ended		Nine Months Ended
	September 30, 2026		September 30, 2025		September 30, 2026	September 30, 2025
Net sales	100.0	%		100.0	%	100.0	%	100.0	%
Gross margin	34.2	%		33.5	%	33.0	%	31.7	%

Selling, general and administrative expenses	18.0	%		19.3	%	19.3	%	22.2	%
Research and development expenses	3.0	%		3.4	%	3.2	%	3.5	%
Restructuring, asset impairment, and other charges	0.4	%		3.3	%	1.2	%	14.6	%
Other operating expense, net	—	%		0.2	%	—	%	—	%
Operating income (loss)	12.7	%		7.3	%	9.3	%	(8.6)	%

Other income (expense), net	0.1	%		0.2	%	0.3	%	(0.6)	%
Interest income, net	0.3	%		0.1	%	0.2	%	0.1	%
Income (loss) before income taxes	13.1	%		7.5	%	9.7	%	(9.0)	%
Income tax expense	3.6	%		3.6	%	3.5	%	2.0	%
Net income (loss)	9.6	%		4.0	%	6.2	%	(10.9)	%


Net Sales and Gross Margin
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Net sales	$	236.1			$	216.0			$	653.4		$	609.3
Gross margin	$	80.7			$	72.3			$	215.7		$	193.3
Percentage of net sales	34.2	%		33.5	%		33.0	%		31.7	%

Net sales increased in the third quarter by 9.3%, or $20.1 million, of which $17.7 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $2.4 million was attributable to favorable foreign currency exchange rates. Sales increased in all end markets, including the electronics and communications, automotive, and aerospace and defense markets, in the third quarter of 2026 compared to the third quarter of 2025.

Net sales increased in the first nine months by 7.2%, or $44.1 million, of which $28.6 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $15.5 million was attributable to favorable foreign currency exchange rates. Sales increased in multiple end markets, including the electronics and communications and industrial markets, in the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.

Gross margin as a percentage of net sales increased approximately 70 basis points to 34.2% in the third quarter of 2026 compared to 33.5% in the third quarter of 2025. Gross margin in the third quarter of 2026 increased due to higher sales volume, favorable mix, and operational efficiencies, partially offset by increased raw material costs.

Gross margin as a percentage of net sales increased approximately 130 basis points to 33.0% in the nine months ended September 30, 2026 compared to 31.7% in the nine months ended September 30, 2025. Gross margin in the nine months ended September 30, 2026 increased due to higher sales volume, favorable mix, and productivity improvements from cost savings following our manufacturing footprint consolidation in Belgium and Germany, partially offset by increased raw material costs.


Selling, General and Administrative Expenses
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Selling, general and administrative expenses	$	42.6			$	41.6			$	126.0		$	134.6
Percentage of net sales	18.0	%		19.3	%		19.3	%		22.2	%

SG&A expenses increased 2.4% in the third quarter of 2026 from the third quarter of 2025, primarily due to an increase in compensation and benefit expense.

SG&A expenses decreased 6.4% in the nine months ended September 30, 2026 from the nine months ended September 30, 2025, primarily due to a $4.4 million reduction in professional services costs, a $1.5 million reduction in software costs, and a $1.0 million reduction in depreciation.


Research and Development Expenses
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Research and development expenses	$	7.0			$	7.4			$	21.0		$	21.5
Percentage of net sales	3.0	%		3.4	%		3.2	%		3.5	%

R&D expenses decreased 5.4% in the third quarter of 2026 from the third quarter of 2025, primarily due to a $0.4 million reduction in R&D trials.

R&D expenses decreased 2.3% in the nine months ended September 30, 2026 from the nine months ended September 30, 2025, primarily due to a reduction in compensation and benefits expense.


Restructuring, Asset Impairment, and Other Charges
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025	September 30, 2026		September 30, 2025
Restructuring, asset impairment, and other charges	$	1.0		$	7.1		$	7.6	$	89.1

We incurred restructuring, asset impairment, and other charges of $1.0 million and $7.6 million in the three and nine months ended September 30, 2026, respectively, due to our footprint consolidation actions in our Eschenbach, Germany facility, the executive leadership transition, additional reductions in force, and the impairment of our Mexico facility lease. For additional information, refer to “Note 13 – Supplemental Financial Information” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.


Other Income (Expense), Net
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025	September 30, 2026		September 30, 2025
Other income (expense), net	$	0.3		$	0.4		$	1.7	$	(3.4)

Other income (expense), net was income of $0.3 million in the third quarter of 2026 compared to income of $0.4 million in the third quarter of 2025. The decrease primarily reflected unfavorable foreign currency impacts, partially offset by favorable copper derivative performance.

Other income (expense), net was income of $1.7 million in the nine months ended September 30, 2026 compared to expense of $3.4 million in the nine months ended September 30, 2025. The increase was primarily due to $6.0 million of favorable year-over-year changes in impacts from foreign currency transactions combined with a $0.9 million increase related to our copper derivative, partially offset by $2.2 million in unfavorable performance on foreign exchange derivative contracts.


Interest Income, Net
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025	September 30, 2026		September 30, 2025
Interest income, net	$	0.6		$	0.2		$	1.2	$	0.9

Interest income, net was $0.6 million in the third quarter of 2026 compared to $0.2 million in the third quarter of 2025. The increase was primarily due to interest income earned related to our short-term investments.

Interest income, net was $1.2 million in the nine months ended September 30, 2026 compared to $0.9 million in the nine months ended September 30, 2025. The increase was primarily due to interest income earned related to our short-term investments.


Income Taxes
	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Income tax expense	$	8.4			$	7.7			$	23.0		$	11.8
Effective tax rate	27.1	%		47.2	%		36.1	%		(21.6)	%

Operating Segment Net Sales and Gross Margin

Advanced Electronics Solutions


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Net sales	$	130.2			$	114.7			$	355.4		$	327.9
Gross margin	$	40.3			$	36.1			$	105.2		$	96.1
Percentage of net sales	31.0	%		31.5	%		29.6	%		29.3	%

AES net sales increased in the third quarter by 13.5%, or $15.5 million, of which $14.2 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $1.3 million was attributable to favorable foreign currency exchange rates. Sales increased in all end markets, including electronics and communications, automotive, and industrial, in the third quarter of 2026 compared to the third quarter of 2025.

AES net sales increased in the first nine months by 8.4%, or $27.5 million, of which $17.7 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $9.8 million was attributable to favorable foreign currency exchange rates. By end market, sales increased for electronics and communications, automotive, and industrial, while sales in the aerospace and defense market were lower, in the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.

Our AES operating and reportable segment gross margin as a percentage of net sales in the third quarter of 2026 was 31.0% compared to 31.5% in the third quarter of 2025. Gross margin declined primarily due to lower absorption from shift in production volumes between regions and increased raw material costs, partially offset by higher sales volumes and favorable mix.

Our AES operating and reportable segment gross margin as a percentage of net sales in the nine months ended September 30, 2026 was 29.6% compared to 29.3% in the nine months ended September 30, 2025. Gross margin improved primarily due to higher sales volume, favorable mix, and productivity improvements from cost savings following our manufacturing footprint consolidation in Belgium and Germany, partially offset by lower utilization from a new production line and increased raw material costs.

Elastomeric Material Solutions


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Net sales	$	101.4			$	97.2			$	284.6		$	269.2
Gross margin	$	38.9			$	34.7			$	105.2		$	92.9
Percentage of net sales	38.4	%		35.7	%		37.0	%		34.5	%

EMS net sales increased in the third quarter by 4.3%, or $4.2 million, of which $3.2 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $1.0 million was attributable to favorable foreign currency exchange rates. By end market, sales increased in the automotive and aerospace and defense markets, partially offset by slightly lower sales in the electronics and communication and industrial market, in the third quarter of 2026 compared to the third quarter of 2025.

EMS net sales increased in the first nine months by 5.7%, or $15.4 million, of which $10.1 million was driven by higher demand and favorable pricing, including increases in average selling prices, and $5.3 million was attributable to favorable foreign currency exchange rates. By end market, sales increased in the industrial, electronics and communications, and aerospace and defense markets, partially offset by lower sales in the automotive market, in the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.

Our EMS operating and reportable segment gross margin as a percentage of net sales in the third quarter of 2026 was 38.4% compared to 35.7% in the third quarter of 2025. Gross margin improved primarily due to increased sales volume, related utilization benefits, and operational efficiencies.

Our EMS operating and reportable segment gross margin as a percentage of net sales in the nine months ended September 30, 2026 was 37.0% compared to 34.5% in the nine months ended September 30, 2025. Gross margin improved primarily due to increased sales volume, related utilization benefits, and productivity improvements.

Other


	Three Months Ended		Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Net sales	$	4.5			$	4.1			$	13.4		$	12.2
Gross margin	$	1.5			$	1.5			$	5.3		$	4.3
Percentage of net sales	33.3	%		36.6	%		39.6	%		35.2	%

Liquidity, Capital Resources and Financial Position

We believe that our existing sources of liquidity and cash flows that we expect to generate from our operations, together with our available credit facilities, will be sufficient to fund our operations, currently planned capital expenditures, and R&D efforts, for at least the next 12 months. We regularly review and evaluate the adequacy of our cash flows, borrowing facilities and banking relationships in an effort to ensure that we have the appropriate access to cash to fund both our near-term operating needs and our long-term strategic initiatives.

The following table illustrates the location of our cash and cash equivalents by our three major geographic areas:


(Dollars in millions)	September 30, 2026		December 31, 2025
U.S.	$	69.4			$	100.1
Europe	49.5			40.7
Asia	87.2			56.2
Total cash and cash equivalents	$	206.1			$	197.0

Approximately $136.7 million of our cash and cash equivalents were held by non-U.S. subsidiaries as of September 30, 2026. We did not make any changes in the nine months ended September 30, 2026 to our position on the permanent reinvestment of our earnings from foreign operations. With the exception of certain of our Chinese subsidiaries, where a substantial portion of our cash and cash equivalents located in Asia are held, we continue to assert that historical foreign earnings are indefinitely reinvested.


(Dollars in millions)	September 30, 2026		December 31, 2025
Key Financial Position Accounts:
Cash and cash equivalents	$	206.1		$	197.0
Short-term investments	$	30.3		$	—
Accounts receivable, net	$	155.4		$	130.6
Inventories, net	$	130.6		$	125.0

Changes in key financial position accounts and other significant changes in our condensed consolidated statements of financial position from December 31, 2025 to September 30, 2026 were as follows:

•Cash and cash equivalents were $206.1 million as compared to $197.0 million as of December 31, 2025, an increase of $9.1 million, or 4.6%. This increase was primarily due to cash provided by operations, partially offset by cash used in investing and financing activities and an unfavorable impact of exchange rates on cash.

•Short-term investments were $30.3 million as compared to nil as of December 31, 2025. The addition of short-term investments was due to the purchase of time deposits with original maturities of more than three months and less than twelve months at the date of purchase, as of September 30, 2026.

•Accounts receivable, net increased 19.0% to $155.4 million as of September 30, 2026 from $130.6 million as of December 31, 2025. The increase was primarily due to higher net sales in the last month of the third quarter of 2026 compared to the last month of the fourth quarter of 2025.

•Inventories were $130.6 million as of September 30, 2026, compared to $125.0 million as of December 31, 2025. The change was due to higher levels of raw materials and finished goods inventory, offset by lower levels of work-in-process inventory.


	Nine Months Ended
(Dollars in millions)	September 30, 2026		September 30, 2025
Key Cash Flow Measures:
Net cash provided by operating activities	$	71.6		$	54.3
Net cash used in investing activities	$	(46.3)		$	(11.2)
Net cash used in financing activities	$	(15.6)		$	(40.0)

Changes in key cash flow measures and other significant changes in our condensed consolidated statements of cash flows from September 30, 2025 to September 30, 2026 were as follows:

•Net cash used in investing activities was $46.3 million as compared to $11.2 million for the nine months ended September 30, 2025, an increase in net cash used of $35.1 million. This increase in net cash used was primarily due to purchases of short-term investments, which consists of time deposits with original maturities of more than three months and less than twelve months at the date of purchase.

•Net cash used in financing activities was $15.6 million as compared to $40.0 million for the nine months ended September 30, 2025, a decrease in net cash used of $24.4 million. This decrease in net cash used was primarily due to a lower level of share repurchase activity.

In 2026, we expect capital spending to be in the range of approximately $30.0 million to $35.0 million. We plan to fund our capital spending in 2026 with cash from operations and cash on hand.

Restrictions on Payment of Dividends

The Fifth Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 as of September 30, 2026.

Contingencies

During the third quarter of 2026, we did not become aware of any material developments related to environmental matters disclosed in our Annual Report, our asbestos litigation or other material contingencies previously disclosed or incur any material costs or capital expenditures related to such matters. Refer to “Note 9 – Commitments and Contingencies” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q for further discussion of these contingencies.

Critical Accounting Policies and Estimates

There have been no material changes in our critical accounting policies and estimates from those disclosed in our Annual Report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our exposure to market risk during the third quarter of 2026. For discussion of our exposure to market risk, refer to “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” contained in our Annual Report.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We conducted, with the participation of our Principal Executive Officer and our Principal Financial Officer, an evaluation of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d- 15(e) under the Exchange Act, as of September 30, 2026. Our disclosure controls and procedures are designed (i) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) to ensure that information required to be

disclosed in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Principal Executive Officer and our Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on their evaluation, our Principal Executive Officer and our Principal Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2026.

Changes in Internal Control over Financial Reporting

We are in the process of a multi-year implementation of a new global ERP system, which will replace our existing operating and financial systems. The implementation is expected to occur in phases over the next several years. The portion of the transition to the new ERP system that we have completed to date did not result in significant changes in our internal control over financial reporting. However, as the next phases of the updated processes are rolled out in connection with the ERP implementation, we will give appropriate consideration to whether these process changes necessitate changes in the design of and the testing for effectiveness of internal controls over financial reporting.

There were no changes in the Company’s internal control over financial reporting during the third quarter of fiscal year ending December 31, 2026, that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act.

Part II - Other Information

Item 1. Legal Proceedings

Refer to the discussion of certain environmental, asbestos, and other litigation matters in “Note 9 – Commitments and Contingencies” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

Item 1A. Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider factors discussed in Part I, Item 1A \"Risk Factors\" of our Annual Report and the Company’s other filings with the SEC, which are available at www.sec.gov and on the Company’s website at www.rogerscorp.com.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Items 2 (a) and (b) are not applicable.


(Dollars in millions, except shares and per share amounts)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
July 1, 2026 to July 31, 2026	67,310	$	127.55		67,310	$	40.2
August 1, 2026 to August 31, 2026	6,138	$	123.99		6,138	$	39.5
September 1, 2026 to September 30, 2026	—	$	—		—	$	39.5

For the three months ended September 30, 2026, we repurchased shares for an aggregate purchase price of $9.3 million under a $200.0 million share repurchase program approved by our Board of Directors. The share repurchase program has no expiration date and may be suspended or discontinued at any time without notice. As of September 30, 2026, $39.5 million remained for repurchase under the share repurchase program. All repurchases were funded through cash generated from operations and cash on hand. Our stock repurchases may occur from time to time through open market purchases, privately negotiated transactions or plans designed to comply with Rule 10b5-1 promulgated under the Exchange Act.

Item 5. Other Information

During the three months ended September 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits


List of Exhibits:

31.1	Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

31.2	Certification of Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.

32	Certification of Principal Executive Officer and Senior Vice President and Chief Financial Officer and Treasurer (Principal Financial Officer) pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.

101	The following materials from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026 formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and September 30, 2025, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2026 and September 30, 2025, (iii) Condensed Consolidated Statements of Financial Position as of September 30, 2026 and December 31, 2025, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and September 30, 2025, (v) Condensed Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2026 and September 30, 2025, (vi) Notes to Condensed Consolidated Financial Statements and (vii) Cover Page.

104	The cover page from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026, formatted in iXBRL and contained in Exhibit 101.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


ROGERS CORPORATION (Registrant)


By: /s/ Laura Russell
Laura Russell
Senior Vice President, Chief Financial Officer and Treasurer
Principal Financial Officer
Dated: October 27, 2026

","original","zhKind","translation","complete",false,"ROG","公司与财报","财报","回购","aihot","/items/onyo7j6p867fb1z3s5udi3c9c","https://www.sec.gov/Archives/edgar/data/84748/000008474826000057/0000084748-26-000057-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1793577600&sig=4b4ab60ed7bbc09f","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1793577600&sig=e088f7e0fbd3f246 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1793577600&sig=18c729d6e21bdeed 96w","changelogVersion","2026-10-01T08:00"]